[{"ATTACHMENTNAME":"5bf215a1-6257-4d03-8928-6511f3d57279.pdf","NEWS_DT":"2022-11-14T14:41:41.42","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call pertaining to the Unaudited Financial Results for quarter and half year ended September 30, 2022.","SCRIP_CD":512529,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"0c2590d5-246f-46cc-b3cf-495d3ccc98be.pdf","NEWS_DT":"2022-08-16T14:57:02.17","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call pertaining to the Unaudited Financial Results for quarter ended June 30, 2022","SCRIP_CD":512529,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"687fecb6-5761-42b1-8bcb-04daae7401ab.pdf","NEWS_DT":"2022-05-30T18:23:25.693","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Audited Financial Results for quarter and year ended March 31, 2022.\r\n\r\nThe same is also available on the Company's website at https://sequent.in/investor-relations.aspx","SCRIP_CD":512529,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]